Literature DB >> 24304392

Chemotherapy as palliative treatment for peritoneal carcinomatosis of gastric origin.

Irene Thomassen1, Nienke Bernards, Yvette R van Gestel, Geert-Jan Creemers, Esther M Jacobs, Valery E Lemmens, Ignace H de Hingh.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24304392     DOI： 10.3109/0284186X.2013.850740

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  5 in total

1.  Cytoreductive surgery and HIPEC in treatment of colorectal peritoneal carcinomatosis: experiment or standard care? A survey among oncologic surgeons and medical oncologists.

Authors:  Hidde J Braam; Djamila Boerma; Marinus J Wiezer; Bert van Ramshorst
Journal:  Int J Clin Oncol       Date:  2015-03-19       Impact factor: 3.402

Review 2.  Advances in the management of peritoneal malignancies.

Authors:  Vahan Kepenekian; Aditi Bhatt; Julien Péron; Mohammad Alyami; Nazim Benzerdjeb; Naoual Bakrin; Claire Falandry; Guillaume Passot; Pascal Rousset; Olivier Glehen
Journal:  Nat Rev Clin Oncol       Date:  2022-09-07       Impact factor: 65.011

3.  Next-Generation Sequencing Analysis of Gastric Cancer Identifies the Leukemia Inhibitory Factor Receptor as a Driving Factor in Gastric Cancer Progression and as a Predictor of Poor Prognosis.

Authors:  Cristina Di Giorgio; Silvia Marchianò; Elisabetta Marino; Michele Biagioli; Rosalinda Roselli; Martina Bordoni; Rachele Bellini; Ginevra Urbani; Angela Zampella; Eleonora Distrutti; Annibale Donini; Luigina Graziosi; Stefano Fiorucci
Journal:  Front Oncol       Date:  2022-06-30       Impact factor: 5.738

4.  Synchronous peritoneal metastases of gastric cancer origin: incidence, treatment and survival of a nationwide Dutch cohort.

Authors:  Willem J Koemans; Robin J Lurvink; Cecile Grootscholten; Rob H A Verhoeven; Ignace H de Hingh; Johanna W van Sandick
Journal:  Gastric Cancer       Date:  2021-01-25       Impact factor: 7.370

5.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II).

Authors:  W J Koemans; R T van der Kaaij; H Boot; T Buffart; A A F A Veenhof; K J Hartemink; C Grootscholten; P Snaebjornsson; V P Retel; H van Tinteren; S Vanhoutvin; V van der Noort; A Houwink; C Hahn; A D R Huitema; M Lahaye; M Los; P van den Barselaar; O Imhof; A Aalbers; G M van Dam; B van Etten; B P L Wijnhoven; M D P Luyer; D Boerma; J W van Sandick
Journal:  BMC Cancer       Date:  2019-05-06       Impact factor: 4.430
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.